Department of Physiology and Biophysics, School of Medicine, Stony Brook University, Stony Brook, NY 11794-8661, USA.
Department of Pharmacology, School of Medicine, Stony Brook University, Stony Brook, NY 11794-8661, USA.
Cells. 2023 Mar 15;12(6):900. doi: 10.3390/cells12060900.
The nonreceptor tyrosine kinase (NRTK) Ack1 comprises a distinct arrangement of non-catalytic modules. Its SH3 domain has a C-terminal to the kinase domain (SH1), in contrast to the typical SH3-SH2-SH1 layout in NRTKs. The Ack1 is the only protein that shares a region of high homology to the tumor suppressor protein Mig6, a modulator of EGFR. The vertebrate Acks make up the only tyrosine kinase (TK) family known to carry a UBA domain. The GTPase binding and SAM domains are also uncommon in the NRTKs. In addition to being a downstream effector of receptor tyrosine kinases (RTKs) and integrins, Ack1 can act as an epigenetic regulator, modulate the degradation of the epidermal growth factor receptor (EGFR), confer drug resistance, and mediate the progression of hormone-sensitive tumors. In this review, we discuss the domain architecture of Ack1 in relation to other protein kinases that possess such defined regulatory domains.
非受体酪氨酸激酶(NRTK)Ack1 由一系列独特的非催化模块组成。其 SH3 结构域位于激酶结构域(SH1)的 C 端,与 NRTKs 中典型的 SH3-SH2-SH1 结构不同。Ack1 是唯一与肿瘤抑制蛋白 Mig6 具有高同源性的蛋白质,Mig6 是 EGFR 的调节剂。脊椎动物 Acks 构成了唯一已知携带 UBA 结构域的酪氨酸激酶(TK)家族。GTPase 结合和 SAM 结构域在 NRTKs 中也不常见。除了作为受体酪氨酸激酶(RTKs)和整合素的下游效应物外,Ack1 还可以作为表观遗传调节剂,调节表皮生长因子受体(EGFR)的降解,赋予药物抗性,并介导激素敏感肿瘤的进展。在这篇综述中,我们讨论了 Ack1 的结构域架构与其他具有此类定义明确的调节结构域的蛋白激酶的关系。